EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor

Term ID

CHEBI:139512

Synonyms

acyl-[acyl-carrier-protein]:NAD+ oxidoreductase inhibitor
acyl-[acyl-carrier-protein]:NAD+ oxidoreductase inhibitors
EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitors
EC 1.3.1.9 inhibitor
EC 1.3.1.9 inhibitors
enoyl-[acyl carrier protein] reductase inhibitor
enoyl-[acyl carrier protein] reductase inhibitors
enoyl-ACP reductase inhibitor
enoyl-ACP reductase inhibitors
ENR inhibitor
ENR inhibitors
NADH-enoyl acyl carrier protein reductase inhibitor
NADH-enoyl acyl carrier protein reductase inhibitors
NADH-specific enoyl-ACP reductase inhibitor
NADH-specific enoyl-ACP reductase inhibitors

Definition

An EC 1.3.1.* (oxidoreductase acting on donor CH-CH group, NAD+ or NADP+ as acceptor) inhibitor that interferes with the action of enoyl-[acyl-carrier-protein] reductase (NADH), EC 1.3.1.9.

References

Wikipedia:Enoyl-acyl_carrier_protein_reductase

Ontology

ChEBI ( EBI )

Relationships

is a type of: EC 1.3.1.* (oxidoreductase acting on donor CH-CH group, NAD(+) or NADP(+) as acceptor) inhibitor

EC 1.3.1.* (oxidoreductase acting on donor CH-CH group, NAD(+) or NADP(+) as acceptor) inhibitor Show first 5 Terms
inverse has_role: atromentin triclosan

atromentin triclosan Show first 5 Terms

Phenotype

Phenotype resulting from EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor

Phenotype where environments contain EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor

Phenotype modified by environments containing EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor

Human Disease / Model Data

Citations